相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Monitoring the activities of Italian colposcopy clinics before and during the COVID-19 pandemic
Giovanni Delli Carpini et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2023)
Cervical cancer, geographical inequalities, prevention and barriers in resource depleted countries
Anna Bogdanova et al.
ONCOLOGY LETTERS (2022)
Immunogenicity and safety of a bivalent, adjuvant system 04-adjuvanted human papillomavirus vaccine in healthy female volunteers aged 15-25: a randomized, double-blind, phase III, noninferiority clinical trial
Seyyedeh Maryam Afshani et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2022)
The cost-effectiveness of human papillomavirus vaccination in the Philippines
Cecilia L. Llave et al.
VACCINE (2022)
Precancerous cervical lesions caused by non-vaccine- preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial
Jaimie Z. Shing et al.
LANCET ONCOLOGY (2022)
Long-term effectiveness of the nine-valent human papillomavirus vaccine in Scandinavian women: interim analysis after 8 years of follow-up
Susanne K. Kjaer et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)
The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study
Milena Falcaro et al.
LANCET (2021)
Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27-45 years of age compared to women 16-26 years of age: An open-label phase 3 study
Elmar A. Joura et al.
VACCINE (2021)
Vaccine exposure during pregnancy among privately and publicly insured women in the United States, 2016-2018
Keran Moll et al.
VACCINE (2021)
Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis
Vincent Daniels et al.
VACCINE (2021)
HPV and Cytology Testing in Women Undergoing 9-Valent HPV Opportunistic Vaccination: A Single-Cohort Follow Up Study
Rosa De Vincenzo et al.
VACCINES (2021)
Risk of cervical intraepithelial neoplasia grade 2 or worse after conization in relation to HPV vaccination status
Freja L. Sand et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Human Papillomavirus Vaccine Effectiveness Against HPV Infection: Evaluation of One, Two, and Three Doses
Lauri E. Markowitz et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Efficacy of the AS04-Adjuvanted HPV16/18 Vaccine: Pooled Analysis of the Costa Rica Vaccine and PATRICIA Randomized Controlled Trials
Joseph E. Tota et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: The CVT Trial
Sabrina H. Tsang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
Efficacy of HPV Vaccination in Women Receiving LEEP for Cervical Dysplasia: A Single Institution's Experience
Marco Petrillo et al.
VACCINES (2020)
Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study
Giorgio Bogani et al.
GYNECOLOGIC ONCOLOGY (2020)
HPV Vaccination and the Risk of Invasive Cervical Cancer
Jiayao Lei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Improvement of Parent's awareness, knowledge, perception, and acceptability of human papillomavirus vaccination after a structured-educational intervention
Mei Neni Sitaresmi et al.
BMC PUBLIC HEALTH (2020)
Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial
Carolina Porras et al.
LANCET ONCOLOGY (2020)
Assessing the Long-Term Role of Vaccination against HPV after Loop Electrosurgical Excision Procedure (LEEP): A Propensity-Score Matched Comparison
Giorgio Bogani et al.
VACCINES (2020)
Is one dose of human papillomavirus vaccine as effective as three?: A national cohort analysis
Julia M. L. Brotherton et al.
PAPILLOMAVIRUS RESEARCH (2019)
SPERANZA project: HPV vaccination after treatment for CIN2+
Alessandro Ghelardi et al.
GYNECOLOGIC ONCOLOGY (2018)
Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial
Warner K. Huh et al.
LANCET (2017)
Recurrence of Human Papillomavirus External Genital Wart Infection Among High-Risk Adults in Montreal, Canada
Rejean Thomas et al.
SEXUALLY TRANSMITTED DISEASES (2017)
Prior human papillomavirus-16/18 AS04-adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post-hoc analysis from a randomized controlled trial
Suzanne M. Garland et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
E. A. Joura et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Coadministration of a 9-Valent Human Papillomavirus Vaccine With Meningococcal and Tdap Vaccines
Andrea Schilling et al.
PEDIATRICS (2015)
Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial
Orestis A. Panagiotou et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial
Orestis A. Panagiotou et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
The incidence of human papillomavirus infection following treatment for cervical neoplasia: A systematic review
Anne F. Rositch et al.
GYNECOLOGIC ONCOLOGY (2014)
Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study
S. Rachel Skinner et al.
LANCET (2014)
Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2-3)?
Woo Dae Kang et al.
GYNECOLOGIC ONCOLOGY (2013)
Efficacy of the HPV-16/18 AS04-Adjuvanted Vaccine Against Low-Risk HPV Types (PATRICIA Randomized Trial): An Unexpected Observation
Anne Szarewski et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data
Elmar A. Joura et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males
Anna R. Giuliano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
J. Paovonen et al.
LANCET (2009)
Pregnancy and Infant Outcomes in the Clinical Trials of a Human Papillomavirus Type 6/11/16/18 Vaccine A Combined Analysis of Five Randomized Controlled Trials
Suzanne M. Garland et al.
OBSTETRICS AND GYNECOLOGY (2009)
Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection - A randomized trial
Allan Hildesheim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases
Suzanne M. Garland et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)